A non-invasive liquid biopsy test is in the works at the Johns Hopkins Kimmel Cancer Center. Researchers are trying to pinpoint the possibility that prostate cancer will eventually be able to be tested for with a liquid that is attempting to detect abnormalities within the urine. These abnormalities would eventually be able to detect any signs of prostate cancer by comparing the RNA and other metabolic chemicals. Although these tests are still being done, this can be something many people would feel relieved about. Most processes of detecting prostate cancer are not only invasive, they are not 100% guaranteed to detect cancer.
Simple, Non-Invasive Advancement Against Prostate Cancer
As one of the most common forms of cancer in men, prostate cancer has been plaguing the world for a long time. However, due to normal invasive testing, we still don’t have a tried and true way to test for prostate cancer with 100% success. The goal of these studies has been to find a non-invasive way to detect prostate cancer with complete accuracy. This noninvasive liquid biopsy looks for RNA and metabolic chemicals within the urine that could signify if prostate cancer was true. The researchers at the Johns Hopkins Kimmel Cancer Center discovered that there are cancer-specific changes within urine RNA and other metabolites that could definitely be tested for.
Lessening the Difficulty and Inaccuracy of Current Invasive Prostate Cancer Tests
Thanks to a combination of RNA deep-sequencing and mass spectrometry, these cancer specific changes within the RNA and dietary byproducts have been found. After much more testing and working with larger groups of patients to ensure complete accuracy, these urine tests will soon be available. Many people are too scared or worried to have prostate cancer testing done. This is due to the invasive and not as accurate results. If these non-invasive tests are tried and true, then this will be a game changer for Urologists.